Tissue engineering is a tissue engineering field that makes use of a complex combination of biotechnology, tissue culture, engineering, micro-fabrication, and suitable biochemical and physical factors to restore, enhance, or replace various types of living tissue. This engineering branch has experienced significant progress over the past three decades. Tissue engineering is commonly used for replacing or improving the functionality of a damaged, missing, or abnormal part of the body such as the eye, lung, or heart. Other areas of tissue engineering that have undergone significant development and growth include tissue engineering for disease management and repair, tissue engineering for the regeneration of tissue and organs, and tissue engineering for cosmetic and functional enhancement.
Growing initiatives by key players in the field of effective regenerative treatments due to the rising prevalence of diabetes and other disorders are driving the growth of the tissue engineering market. Moreover, technological advancements in the field of 3D tissue engineering, for example, organ-on-a-chip technology, replacement of embryo cells with stem cells, and utilization of 3D bioprinters that can efficiently produce in vitro implants, are again projected to foster the growth of the market. Furthermore, increasing government funding for medical and academic research activities is further expected to augment the growth of the market. Additionally, the growing prevalence of musculoskeletal, Orthopedics, and spine that require musculoskeletal disorders will stimulate the growth of the market. As per the U.S. Medicare and Medicaid facility, there are around 900,000 surgeries every year that require bone replacement or reconstruction. The healthcare burden in the U.S. is increased by USD 60 billion owing to the incidence of nearly 15 million fracture cases annually.
North America is expected to gain significant growth over the forecast period and this is attributed to the increased funding in the field of regenerative medicine. According to the report published by the National Institutes of Health (NIH), (U.S.) funding for stem cell research and regenerative medicine was USD 1.8 and USD 1.0 billion respectively in 2018. The NIH estimates for funding in 2020 for these two areas correspond to USD 1.7 billion, and USD 915 million respectively.
Key Developments:
In March 2019, ACell and MyungMoon Bio Co. Ltd. signed an exclusive distribution agreement for the distribution of ACell’s Cytal Wound Matrix and MicroMatrix wound management solutions in South Korea. MyungMoon is a reputed distributor and manufacturer of drugs and medical devices in South Korea.
Key features of the study:
- This report provides in-depth analysis of the tissue engineering market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global tissue engineering market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global tissue engineering market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Tissue Engineering Market, By Material Type:
Synthetic
Biological
Others
Global Tissue Engineering Market, By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Global Tissue Engineering Market, By Region:
North America
By Country:
U.S.
Canada
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Africa
By Country:
South Africa
Central Africa
North Africa
By Material Type:
Synthetic
Biological
Others
By Application:
Dermal
Orthopedic
Dental
Neurology
Others
Company Profiles
Acelity L.P. Inc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Allergan Plc.
Athersys, Inc.
Braun
BioMimetic Therapeutics
Bio Tissue Technologies
R. Bard
International Stem Cell
Integra Lifesciences
Medtronic, Inc.
Organogenesis Inc.
Osiris Therapeutics
RTI surgical, Inc.
Stryker Corporation
Tissue Regenix Group Plc.
Zimmer Biomet
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Material Type
o Market Snippet, By Application
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Technological Advancements
o Reimbursement Scenario
o Epidemiology Analysis
o PEST Analysis
4. Global Tissue Engineering Market, By Material Type, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Synthetic
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Biological
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Tissue Engineering Market, By Application, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Dermal
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Orthopedic
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Dental
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Neurology
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
6. Global Tissue Engineering Market, By Region, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2016 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Acelity L.P. Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Allergan Plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Athersys, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o B. Braun
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o BioMimetic Therapeutics
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Bio Tissue Technologies
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o C. R. Bard
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o International Stem Cell
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Integra Lifesciences
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Medtronic, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Organogenesis Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Osiris Therapeutics
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o RTI surgical, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Stryker Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Tissue Regenix Group Plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Zimmer Biomet
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About Us and Sales Contact
*Browse 21 market data tables and 24 figures on "Tissue Engineering Market" - Global forecast to 2026".
Request Discount 
Inquire Before Buy
